Anal Cancer: Signs, the HPV Cause & Treatment in Hyderabad

Yes, often — especially when found early. Most anal cancers that have not spread can be cured with chemoradiation (chemotherapy given together with radiation), without major surgery. More advanced disease is treated with chemotherapy and immunotherapy to control it. Your outlook depends mainly on the stage, which your team explains after scans and tests.

Usually not. The standard treatment — chemoradiation — cures most anal cancers while preserving the anus, so a permanent colostomy is avoided. Surgery with a colostomy is reserved for the minority of cases where the cancer does not respond or comes back. For anal cancer this is the opposite of what many people fear.

Usually it is piles (haemorrhoids), a fissure or another benign cause — not cancer. But anal bleeding, a lump, pain or discharge that lasts more than two weeks, or occurs with risk factors, should be checked. It is understandable to feel embarrassed, but getting checked early is worth it — and a specialist sees these symptoms every day, in a private, respectful setting.

The commonest first sign is bleeding from the back passage, which is often mistaken for piles. Other signs include a lump or swelling near the anus (which may be painless at first), anal pain or a feeling of pressure, persistent itching, and discharge. Anything lasting more than two weeks, or getting worse, is worth a check.

Most anal cancers are linked to persistent infection with high-risk HPV — the same common virus behind most cervical cancers. HPV is extremely common and usually clears on its own; only a small number of long-lasting infections lead to cancer. This is not about blame, and the HPV vaccine can reduce the risk.

The HPV vaccine protects against the high-risk HPV types that cause most anal cancers, and it also protects against cervical and several other HPV-related cancers. It works best when given before exposure to the virus — which is why it is recommended for both boys and girls — but prevention advice for adults should be discussed with a doctor.

No — in fact women are about twice as likely as men to develop anal cancer. It can affect anyone, which is why persistent symptoms should be taken seriously regardless of gender.

Diagnosis starts with a private consultation and a gentle examination, followed by an anoscopy (which lets the specialist see the anal canal) and a biopsy — a small tissue sample that confirms the diagnosis. MRI of the pelvis and a PET-CT scan are then used to stage the cancer. A biopsy is safe and does not spread cancer; it is the only way to be certain.

Chemoradiation means chemotherapy given together with radiation therapy. For anal cancer it is the primary, organ-preserving treatment: it cures most cases while keeping the anus intact, which is why major surgery and a permanent colostomy are usually avoided. It is typically given daily over about six weeks.

Chemoradiation for anal cancer usually runs daily over roughly six weeks, followed by a period of recovery and monitoring. The tumour can take several months to fully disappear after treatment finishes, so your team monitors closely rather than rushing to surgery. Your exact timeline is confirmed once the stage and plan are set.

Anal cancer is grouped into stages I to IV, based on the tumour's size and whether it has reached lymph nodes or distant organs. Stage I is a small tumour limited to the anal canal; Stage II is larger but still local; Stage III has reached nearby lymph nodes in the pelvis or groin; and Stage IV has spread to distant organs. Most stages without distant spread are treated with chemoradiation aiming for cure.

Cost depends on the stage and treatment given, so it is best provided as an indicative range after assessment. Because anal cancer is treated mainly with chemoradiation, and eligible radiation and treatment may be covered under Aarogyasri or PMJAY at empanelled centres, support is often available. Use the estimator on this page for an indicative figure, then request a callback for an exact estimate.

For eligible patients, yes. Under Aarogyasri and PMJAY, eligible anal cancer treatment — including the radiation that is central to chemoradiation — may be largely covered at empanelled centres. Our team helps you check eligibility and complete the paperwork, and guides you on private insurance and EMI if a scheme does not apply.

No. Anal cancer begins in the anal canal — the short passage at the very end of the bowel — and is usually a squamous cell carcinoma linked to HPV. Rectal cancer begins higher up, in the rectum, and is a different disease with a different cause and different treatment. The distinction matters because anal cancer is treated mainly with chemoradiation rather than the major surgery some rectal cancers need.

In part, yes. Because most anal cancers are HPV-driven, the HPV vaccine (given before exposure) lowers the risk, as does not smoking. People with a weakened immune system or a history of HPV-related cancers such as cervical cancer benefit from regular check-ups. Acting early on persistent symptoms does not prevent cancer but greatly improves the outlook.

No. Anal cancer is not infectious — you cannot catch it from someone by sharing food, using the same toilet, or ordinary contact, and caring for someone with it is completely safe. HPV, the virus linked to it, is a common infection, but the cancer itself is not contagious.

No. A biopsy is a safe, standard step performed under controlled conditions and does not spread cancer. It is the only reliable way to confirm whether a symptom is anal cancer. The real danger is delaying the check, not the biopsy itself.

Standard external-beam radiotherapy does not make you radioactive, and you can safely be around family and children. However, pelvic radiation can affect fertility and sexual health, so if this matters to you, tell your team before treatment begins — options and supportive care can often be arranged, and we discuss this sensitively.

Because anal cancer is treated primarily with radiation-based chemoradiation, care is led by a radiation oncologist, working with medical and surgical oncologists. At CION your case is reviewed by this team together in a multidisciplinary tumour board, so you get a coordinated plan rather than a single-doctor decision. Persistent anal bleeding, a lump, pain or discharge should be assessed by an oncologist.

It can, which is why structured follow-up matters. After chemoradiation the tumour may take months to disappear fully, so your team monitors closely before considering any further treatment, and reviews you regularly afterwards to catch any recurrence early. Not smoking and attending follow-up appointments both help.